Cas:252256-43-2 (Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt manufacturer & supplier

We serve Chemical Name:(Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt CAS:252256-43-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt

Chemical Name:(Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt
CAS.NO:252256-43-2
Synonyms:L-Seryl-L-α-glutamyl-L-valyl-L-lysyl-L-valyl-L-α-aspartyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-L-arginine;(val671)-app770 (667-676);[val671]-amyloid b/a4 protein precursor 770 fragment 667-676 trifluoroacetate salt;h-ser-glu-val-lys-val-asp-ala-glu-phe-arg-oh;L-Arginine, L-seryl-L-α-glutamyl-L-valyl-L-lysyl-L-valyl-L-α-aspartyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-;[val671]-a4 protein precursor 770 fragment 667-676 trifluoroacetate salt;ser-glu-val-lys-val-asp-ala-glu-phe-arg;[Val671]-Amyloid b/A4 Protein Precursor770 (667-676)
Molecular Formula:C51H82N14O18
Molecular Weight:1179.280
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.5±0.1 g/cm3
Index of Refraction:1.637
PSA:545.27000
Exact Mass:1178.593140
LogP:-2.33

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like L-Seryl-L-α-glutamyl-L-valyl-L-lysyl-L-valyl-L-α-aspartyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-L-arginine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[Val671]-Amyloid b/A4 Protein Precursor770 (667-676) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,h-ser-glu-val-lys-val-asp-ala-glu-phe-arg-oh Use and application,[val671]-a4 protein precursor 770 fragment 667-676 trifluoroacetate salt technical grade,usp/ep/jp grade.


Related News: Australia has started denying entry to all travelers who have come from or transited through mainland China. (Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt manufacturer Australia has started denying entry to all travelers who have come from or transited through mainland China. (Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt supplier From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend. (Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt vendor Australia has started denying entry to all travelers who have come from or transited through mainland China. (Val671)-Amyloid β/A4 Protein Precursor770 (667-676) trifluoroacetate salt factory In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.